Investors & Media

AIM Rule 26

Amryt Pharma’s strategy is to build a specialty pharmaceutical company focused on the development and commercialisation of drugs to treat rare and orphan diseases.

Regulatory News

25 May 2017

Result of AGM

25 May 2017

AGM Statement

Admission Doc & Circulars

Elevator Pitch

Amryt Pharma Presentation


CEO Joe Wiley discusses the strategy to become a significant player in the orphan drug space and also talks through the Company presentation.

Biotech and Money Profile on Amryt Pharma.

Email Alerts

Subscribe to Our Newsletter:

Delivered by Investis – link to website (opens in a new window)